Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

G Targher, L Bertolini, F Poli, S Rodella, L Scala… - Diabetes, 2005 - Am Diabetes Assoc
Nonalcoholic fatty liver disease (NAFLD) is closely correlated to several metabolic syndrome
features. We assessed prospectively whether NAFLD predicts future cardiovascular disease …

Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease

G Targher, L Bertolini, L Scala, M Cigolini… - Nutrition, Metabolism …, 2007 - Elsevier
BACKGROUND AND AIM: To explore associations between serum 25-hydroxyvitamin D3
[25 (OH) D] concentrations and liver histology in patients with non-alcoholic fatty liver …

[HTML][HTML] Brazilian guidelines of hypertension–2020

WKS Barroso, CIS Rodrigues, LA Bortolotto… - Arquivos brasileiros de …, 2021 - SciELO Brasil
SciELO - Brasil - Diretrizes Brasileiras de Hipertensão Arterial – 2020 Diretrizes Brasileiras de
Hipertensão Arterial – 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos …

Nearly ubiquitous tissue distribution of the scrapie agent precursor protein

PE Bendheim, HR Brown, RD Rudelli, LJ Scala… - Neurology, 1992 - AAN Enterprises
The “modified host protein” model of scrapie proposes that the transmissible agent is
composed of the degradation-resistant protein, Sp33–37, and that clinical and pathologic …

Serum 25‐hydroxyvitamin D3 concentrations and carotid artery intima‐media thickness among type 2 diabetic patients

…, L Bertolini, R Padovani, L Zenari, L Scala… - Clinical …, 2006 - Wiley Online Library
Objective To estimate the prevalence of hypovitaminosis D among type 2 diabetic adults and
to assess the relationship between hypovitaminosis D and intimal medial thickening (IMT) of …

Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non‐alcoholic fatty liver disease

…, L Bertolini, R Padovani, F Poli, L Scala… - Diabetic …, 2006 - Wiley Online Library
Aims To estimate the prevalence of cardiovascular disease (CVD) in Type 2 diabetic
patients with and without non‐alcoholic fatty liver disease (NAFLD), and to assess whether …

Non‐alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non‐diabetic men. Role of visceral …

G Targher, L Bertolini, L Scala, G Zoppini… - Diabetic …, 2005 - Wiley Online Library
Aims To compare plasma biomarkers of inflammation and endothelial dysfunction in
individuals with and without non‐alcoholic hepatic steatosis (HS), and to evaluate whether …

[HTML][HTML] Updated cardiovascular prevention guideline of the Brazilian Society of Cardiology-2019

DB Precoma, GMM Oliveira, AF Simao… - Arquivos brasileiros de …, 2019 - SciELO Brasil
Level of evidence Level A Data obtained from multiple concordant large randomized trials
and/or robust meta-analysis of randomized clinical trials Level B Data obtained from less …

Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

…, L Bertolini, S Rodella, G Zoppini, L Scala… - Clinical …, 2006 - Wiley Online Library
Objectives To explore associations between plasma adiponectin concentrations and liver
histology in patients with nonalcoholic fatty liver disease (NAFLD). Design and patients In a …

Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients

…, L Bertolini, R Padovani, F Poli, L Scala… - Journal of …, 2006 - Springer
Non-alcoholic fatty liver disease (NAFLD) is closely associated with several metabolic
syndrome (MetS) features. We assessed whether NAFLD is significantly associated with …